Status:
COMPLETED
Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Post Thrombotic Syndrome
Deep Vein Thrombosis
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Centers that participated in the HOKUSAI VTE trial will be invited to collect follow of previously enrolled patients at least 2 years after the index VTE.
Detailed Description
HOKUSAI VTE trial was a randomised double blind non inferiority trial that compared the efficacy and safety of heparin ) (enoxaparin or unfractionated heparin) followed by edoxaban with heparin (enoxa...
Eligibility Criteria
Inclusion
- patient who participated in the HOKUSAI VTE trial
Exclusion
- patient deprived of liberty
- patient under guardianship
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 3 2020
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT03757481
Start Date
January 1 2018
End Date
March 3 2020
Last Update
October 3 2023
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Amiens University Hospital
Amiens, France
2
Angers University Hospital
Angers, France
3
Brest University Hospital
Brest, France
4
Clermont-Ferrand University Hospital
Clermont-Ferrand, France